CELLTRION, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 192,900 KRW | +1.69% |
|
+2.88% | -4.27% |
| May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
| Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLTRION, INC. | Other Biotechnology & Medical Research | +1.69% | +2.88% | -4.27% | +12.28% | +4.36% | 29.04B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A068270 Stock
- Charts Celltrion, Inc.
- Comparison Chart